共 51 条
- [1] Watkins H(2011)Inherited cardiomyopathies N. Engl. J. Med. 364 1643-1656
- [2] Ashrafian H(2017)Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy Circ. Res. 121 749-770
- [3] Redwood C(2017)Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy Circulation 136 2420-2436
- [4] Marian AJ(2018)Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study Int. J. Cardiol. 273 130-135
- [5] Braunwald E(2019)Novel oral anticoagulants for primary stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation Stroke 50 2582-2586
- [6] Rowin EJ(2020)2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation 142 e533-e557
- [7] Choi YJ(2016)Stroke and embolic events in hypertrophic cardiomyopathy: Risk stratification in patients without atrial fibrillation Stroke 47 936-942
- [8] Lee HJ(2019)Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation: A nationwide cohort study Aging 11 11347-11357
- [9] Ommen SR(2022)Ischemic stroke in patients with hypertrophic cardiomyopathy according to presence or absence of atrial fibrillation Stroke 53 497-504
- [10] Haruki S(2014)Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: Systematic review Heart 100 465-472